BMY Jun 2024 46.000 put
| Previous close | 3.4000 |
| Open | 3.7100 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 46.00 |
| Expiry date | 2024-06-21 |
| Day's range | 3.4000 - 3.7100 |
| Contract range | N/A |
| Volume | |
| Open interest | 4.24k |
Business WireBristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
PRINCETON, N.J., May 23, 2024--Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
BenzingaHawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M
A judge in Hawaii has reportedly ordered Bristol Myers Squibb & Co (NYSE:BMY) and Sanofi SA (NASDAQ:SNY) to pay the state over $916 million for failing to warn non-white patients about health risks associated with their blood thinner Plavix. This decision marks an increase from an earlier $834 million judgment. Judge James Ashford of Hawaii’s First Circuit Court’s ruling follows a non-jury trial held last fall and represents the second trial in this case. The state’s Supreme Court had previously
ZacksBristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
The FDA assigns a new target action date of Dec 29, 2024, to Bristol Myers (BMY) BLA for subcutaneous nivolumab (nivolumab and hyaluronidase).
